Here, this unexpected role of IL-23R signaling in stabilizing Treg suppressive functions sets the sound base for the therapeutic targeting of Treg cells through IL-23 or IL-23R blockade to expand the armamentarium of cancer immunotherapy. This evidence concerns the gene IL23R and cancer.